Pet Pharm Biotech Co., Ltd. (TPEX:7762)
52.60
+1.40 (2.73%)
At close: Oct 30, 2026
| Market Cap | 3.06B -23.4% |
| Revenue (ttm) | 265.54M +67.0% |
| Net Income | 30.03M +56.0% |
| EPS | 0.52 +24.9% |
| Shares Out | 58.09M |
| PE Ratio | 102.11 |
| Forward PE | n/a |
| Dividend | 0.25 (0.47%) |
| Ex-Dividend Date | Jul 20, 2026 |
| Volume | 74,976 |
| Open | 51.30 |
| Previous Close | 51.20 |
| Day's Range | 50.70 - 52.60 |
| 52-Week Range | 44.00 - 76.75 |
| Beta | 0.72 |
| Analysts | n/a |
| Price Target | n/a |
| Est. Earnings | Nov 13, 2026 |